S. Spranger

Immunology · 2013–2019

A researcher in the Science corpus: 6 papers; trusts 4 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom S. Spranger trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Rosenberg
  2. T. Gajewski
  3. J. Fontenot
  4. G. Barber
  5. N. Restifo
  6. T. Mempel
  7. S. Topalian

Who trusts S. Spranger overall

  1. A. Schoenfeld
  2. Lieping Chen
  3. M. Hellmann
  4. Antoni Ribas
  5. Russell W. Jenkins
  6. D. Dai
  7. Xue Han
  8. W. Zou
  9. T. Gajewski
  10. D. Thommen

Papers from S. Spranger's perspective

Ordered by how strongly the researchers S. Spranger trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  2. Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment (Cancer Research)
  3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  4. An immune-active tumor microenvironment favors clinical response to ipilimumab (Cancer Immunology and Immunotherapy)
  5. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. (Immunity)
  6. How dying cells alert the immune system to danger (Nature reviews. Immunology)
  7. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors (Nature Medicine)
  8. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells (Journal of Experimental Medicine)
  9. Type I interferon is selectively required by dendritic cells for immune rejection of tumors (Journal of Experimental Medicine)
  10. Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)

Their papers